Arrowhead Pharmaceuticals Inc.
NASDAQ:ARWR 10:06:17 AM EDT
Market Cap (Intraday) | 3.51B |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $28.45 |
50-Day MA | $31.16 |
200-Day MA | $30.09 |
Arrowhead Pharmaceuticals Inc. Stock, NASDAQ:ARWR
177 East Colorado Boulevard, Suite 700, Pasadena, California 91105
United States of America
Phone: +1.626.304.3400
Number of Employees: 525
Description
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.